Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Factors Affecting Erythropoiesis01:24

Factors Affecting Erythropoiesis

The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Overview of Hematopoiesis01:20

Overview of Hematopoiesis

Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Erythropoiesis01:14

Erythropoiesis

Red blood cells  (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia, and...
Rh Blood Group01:19

Rh Blood Group

The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Observed Mealtime Interactions, Meal Healthfulness, and Childhood Obesity Among Low-Income Families.

Pediatric obesity·2026
Same author

Comparing neuroprotective drug efficacy in rodent neonatal brain injury models.

Pediatric research·2026
Same author

Antihypertensive Combinations Modify Cardiovascular Risk Factor Importance: A Machine Learning Analysis of the ACCOMPLISH Trial.

Journal of clinical hypertension (Greenwich, Conn.)·2026
Same author

Unintended Consequences of A Quality Improvement Initiative on Racial Inequity in Newborn Drug Testing.

Hospital pediatrics·2026
Same author

Disparities in Pediatric Admissions for Growth Faltering.

Hospital pediatrics·2026
Same author

Work as a Predictor of Ethylenethiourea (ETU) Exposure During Pregnancy Among Participants Enrolled in the SEMILLA Birth Cohort Study.

Toxics·2025

Related Experiment Video

Updated: Jul 18, 2026

Quantitating Iron Transport Across the Mouse Placenta In Vivo Using Nonradioactive Iron Isotopes
08:45

Quantitating Iron Transport Across the Mouse Placenta In Vivo Using Nonradioactive Iron Isotopes

Published on: May 10, 2022

Iron deficiency in infancy: applying a physiologic framework for prediction.

Betsy Lozoff1, Niko Kaciroti, Tomás Walter

  • 1Center for Human Growth and Development, University of Michigan, Ann Arbor, MI 48109-0406, USA. blozoff@umich.edu

The American Journal of Clinical Nutrition
|December 13, 2006
PubMed
Summary

Infant iron deficiency is common. Predictors vary with iron supplementation, highlighting the need for early iron status data in research comparisons.

More Related Videos

A Point-of-Care Method with Integrated Decision Support Tool to Estimate Anemia at Population Level
05:35

A Point-of-Care Method with Integrated Decision Support Tool to Estimate Anemia at Population Level

Published on: January 19, 2024

Measurement of Tissue Non-Heme Iron Content using a Bathophenanthroline-Based Colorimetric Assay
05:08

Measurement of Tissue Non-Heme Iron Content using a Bathophenanthroline-Based Colorimetric Assay

Published on: January 31, 2022

Related Experiment Videos

Last Updated: Jul 18, 2026

Quantitating Iron Transport Across the Mouse Placenta In Vivo Using Nonradioactive Iron Isotopes
08:45

Quantitating Iron Transport Across the Mouse Placenta In Vivo Using Nonradioactive Iron Isotopes

Published on: May 10, 2022

A Point-of-Care Method with Integrated Decision Support Tool to Estimate Anemia at Population Level
05:35

A Point-of-Care Method with Integrated Decision Support Tool to Estimate Anemia at Population Level

Published on: January 19, 2024

Measurement of Tissue Non-Heme Iron Content using a Bathophenanthroline-Based Colorimetric Assay
05:08

Measurement of Tissue Non-Heme Iron Content using a Bathophenanthroline-Based Colorimetric Assay

Published on: January 31, 2022

Area of Science:

  • Pediatrics
  • Nutritional Science
  • Hematology

Background:

  • Infants aged 6-24 months face significant risk of iron deficiency.
  • Identifying predictors of iron deficiency in this age group is crucial for public health.

Purpose of the Study:

  • To apply a physiologic model to identify iron deficiency risk factors in infants.
  • To evaluate how iron supplementation affects these risk factors.

Main Methods:

  • A study of 1657 Chilean infants (12 months old) randomly assigned to different iron supplementation groups.
  • Analysis of venous blood biomarkers including hemoglobin, ferritin, and mean corpuscular volume.
  • Logistic regression models used to identify predictors of iron deficiency anemia and iron deficiency without anemia.

Main Results:

  • The prevalence of iron deficiency was 34.9% at 12 months.
  • Lower 6-month hemoglobin was the strongest predictor of iron deficiency.
  • Birth factors (weight, gestation) predicted deficiency in no-added-iron and high-iron groups, but predictors varied with supplementation.

Conclusions:

  • Predictors of infant iron deficiency differ based on iron supplementation levels.
  • Direct comparison of studies is challenging without consistent data on early iron status and supplementation conditions.